Seminars in Radiation Oncology
Volume 17, Issue 2 , Pages 149-155 , April 2007

Genetic Susceptibility To Late Normal Tissue Injury

  • Elizabeth L. Travis, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Elizabeth L. Travis, PhD, Department of Experimental Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0066, Houston, TX 77030.

References 

  1. Yabroff KR, Lawrence WF, Clauser S, et al. Burden of illness in cancer survivors: Findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–1330
  2. Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: Challenge and opportunity. Semin Radiat Oncol. 2003;13:248–266
  3. Gauldie J. Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002;165:1205–1206
  4. Strieter RM. Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002;165:1206–1207
  5. Turreson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys. 1990;19:1569–1574
  6. Safwat A, Bentzen SM, Turesson I, et al. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:198–204
  7. Abadir R, Hakami N. Ataxia telangiectasia with cancer (An indication for reduced radiotherapy and chemotherapy doses). Br J Radiol. 1983;56:343–345
  8. Alter BP. Radiosensitivity in Fanconi’s anemia patients. Radiother Oncol. 2002;62:345–347
  9. Gatti RA. The inherited basis of human radiosensitivity. Acta Oncol. 2001;40:702–711
  10. Taylor AMR, Harnden DG, Arlett CF, et al. Ataxia telangiectasia: A human mutation with abnormal radiation sensitivity. Nature. 1975;258:427–429
  11. Hart RM, Kimler BF, Evans RG, et al. Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int J Radiat Oncol Biol Phys. 1987;13:1237–1240
  12. Geara FB, Peters LJ, Ang KK, Wike J, et al. Radiosensitivity measurement of keratinocytes and fibroblasts from radiotherapy patients. Int J Radiat Oncol Biol Phys. 1992;24:287–293
  13. Haston CK, Travis EL. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res. 1997;57:5286–5291
  14. Franko AJ, Sharplin J, Ward WF, et al. The genetic basis of strain-dependent differences in the early phase of radiation injury in mouse lung. Radiat Res. 1991;126:349–356
  15. Franko AJ, Sharplin J, Ward WF, et al. Evidence for two patterns of inheritance of sensitivity to induction of lung fibrosis in mice by radiation, one of which involves two genes. Radiat Res. 1996;146:68–74
  16. Haston CK, Zhou X, Gumbiner-Russo L, et al. Universal and radiation-specific loci influence murine susceptibility to radiation-induced pulmonary fibrosis. Cancer Res. 2002;62:3782–3788
  17. Haston CK, Tomko TG, Godin N, et al. Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions. J Med Genet. 2005;42:464–473
  18. Haston CK, Amos CI, King TM, et al. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res. 1996;56:2596–2601
  19. Haston CK, Wang M, Dejournett RE, et al. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum Mol Genet. 2002;11:1855–1863
  20. Kleeberger SR. Genetic susceptibility to ozone exposure. Toxicol Lett. 1995;82-83:295–300
  21. Kleeberger SR, Bassett DJP, Jakab GJ, et al. A genetic model for evaluation of susceptibility to ozone-induced inflammation. Am J Physiol. 1990;264:L313–L320
  22. Kleeberger SR, Levitt RC, Zhang LY. Susceptibility to ozone-induced inflammation. II (Separate loci control responses to acute and subacute exposures). Am J Physiol. 1993;264:L21–L26
  23. Kleeberger SR, Levitt RC, Zhang LY. Susceptibility to ozone-induced inflammation. I. Genetic control of the response to subacute exposure. Am J Physiol. 1993;264:L15–L20
  24. Kleeberger SR, Levitt RC, Zhang LY, et al. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice (Letter). Nat Genet. 1997;17:475–478
  25. Kleeberger SR. Genetic aspects of susceptibility to air pollution. Eur Respir J Suppl. 2003;40:52s–56s
  26. Kleeberger SR. Genetic aspects of pulmonary responses to inhaled pollutants. Exp Toxicol Pathol. 2005;57(suppl 1):147–153
  27. Frankel WN. Taking stock of complex trait genetics in mice. Trends Genet. 1995;11:471–477
  28. Lindblad-Toh K, Winchester E, Daly MJ, et al. Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat Genet. 2000;24:381–386
  29. Sharplin J, Franko AJ. Quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the early phase. Radiat Res. 1989;119:1–14
  30. Johnston CJ, Piedboeuf B, Rubin P, Williams JP, Baggs R, Finkelstein JN. Early and persistent alterations in the expression of interleukin-1a, interleukin01b and tumor necrosis factor a mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res. 1996;145:762–767
  31. Johnston CJ, Williams JP, Okunieff P, et al. Radiation-induced pulmonary fibrosis: Examination of chemokine and chemokine receptor families. Radiat Res. 2002;157:256–265
  32. Johnston CJ, Wright TW, Rubin P, et al. Alterations in the expression of chemokine mRNA levels in fibrosis-resistant and -sensitive mice after thoracic irradiation. Exp Lung Res. 1998;24:321–337
  33. Kolb M, Bonniaud P, Galt T, et al. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of “fibrosis-prone” and “fibrosis-resistant” mouse strains. Am J Respir Cell Mol Biol. 2002;27:141–150
  34. Du M, Irani R, Stivers DN, et al. H2 ea deficiency is a risk factor for bleomycin induced lung fibrosis in mice. Cancer Res. 2004;64:6835–6839
  35. Nadeau JH, Singer JB, Matin A, et al. Analysing complex genetic traits with chromosome substitution strains. Nat Genet. 2000;24:221–225
  36. Wills-Karp M, Ewart SL. Time to draw breath: Asthma-susceptibility genes are identified. Nat Rev Genet. 2004;5:376–387
  37. Karp CL, Grupe A, Schadt E, et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol. 2000;1:221–226
  38. Eaves IA, Wicker LS, Ghandour G, et al. Combining mouse congenic strains and microarray gene expression analysis to study a complex trait: The NOD model of type 1 diabetes. Genome Res. 2002;12:232–243
  39. Rikke BA, Johnson TE. Towards the cloning of genes underlying murine QTLs. Mamm Genome. 1998;9:963–968
  40. Sheppard D. Uses of expression microarrays in studies of pulmonary fibrosis, asthma, acute lung injury, and emphysema. Chest. 2002;121:21S–25S
  41. Sandford A, Weir T, Pare P. The genetics of asthma. Am J Respir Crit Care Med. 1996;153:1749–1765
  42. Bauer AK, Malkinson AM, Kleeberger SR. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: Genetic similarities. Am J Physiol Lung Cell Mol Physiol. 2004;287:L685–L703
  43. Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2006;173:188–198
  44. Grutters JC, du Bois RM. Genetics of fibrosing lung diseases. Eur Respir J. 2005;25:915–927
  45. Kleeberger SR, Reddy S, Zhang LY, et al. Genetic susceptibility to ozone-induced lung hyperpermeability: role of toll-like receptor 4. Am J Respir Cell Mol Biol. 2000;22:620–627
  46. Cho HY, Zhang LY, Kleeberger SR. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am J Physiol Lung Cell Mol Physiol. 2001;280:L537–L546
  47. Bitterman PB, Crystal RG. Is there a fibrotic gene?. Chest. 1980;78:549–550
  48. Geara FB, Komaki R, Tucker SL, et al. Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: Evidence for inherent interindividual variation. Int J Radiat Oncol Biol Phys. 1998;41:279–286
  49. Marshall RP, McAnulty RJ, Laurent GJ. The pathogenesis of pulmonary fibrosis: is there a fibrosis gene?. Int J Biochem Cell Biol. 1997;29:107–120
  50. Rossi GA, Szapiel S, Ferrans VJ, et al. Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune-related genes. Am Rev Respir Dis. 1987;135:448–455
  51. Ekimoto H, Takada K, Ohnuki T, et al. Different sensitivity to bleomycin-induced pulmonary fibrosis among various strains of mice. J Clin Biochem Nutr. 1987;2:25–31
  52. Schrier DJ, Kunkel RG, Phan SH. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis. 1983;127:63–66
  53. Baecher-Allan CM, Barth RK. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg Immunol. 1993;5:207–217
  54. Filderman AE, Lazo JS. Murine strain differences in pulmonary bleomycin metabolism. Biochem Pharmacol. 1991;42:195–198
  55. Ohtsuka Y, Brunson KJ, Jedlicka AE, et al. Genetic linkage analysis of susceptibility to particle exposure in mice. Am J Respir Cell Mol Biol. 2000;22:574–581
  56. Honda K, Kimura A, Dong RP, et al. Immunogenetic analysis of silicosis in Japan. Am J Respir Cell Mol Biol. 1993;8:106–111
  57. Weiss RB. Hypersensitivity reactions. Semin Oncol. 1992;19:458–477
  58. Podolin PL, Denny P, Lord CJ, Hill NJ, et al. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. J Immunol. 1997;159:1835–1843
  59. Morel L, Blenman KR, Croker BP, Wakeland EK. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci U S A. 2001;98:1787–1792
  60. Andreassen CN, Alsner J, Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis—Where and how to look for it?. Radiother Oncol. 2002;64:131–140
  61. Russell NS, Begg AC. Editorial radiotherapy and oncology 2002: Predictive assays for normal tissue damage. Radiother Oncol. 2002;64:125–129
  62. Holscher T, Bentzen SM, Baumann M. Influence of connective tissue diseases on the expression of radiation side effects: A systematic review. Radiother Oncol. 2006;78:123–130
  63. Andreassen CN, Alsner J, Overgaard M, et al. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol. 2003;69:127–135
  64. Andreassen CN, Alsner J, Overgaard J, et al. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol. 2005;75:18–21
  65. Bentzen SM, Dorr W, Anscher MS, et al. Normal tissue effects: Reporting and analysis. Semin Radiat Oncol. 2003;13:189–202
  66. Bentzen SM, Thames HD. Incidence and latency of radiation reactions. Radiother Oncol. 1989;14:261–262
  67. Bentzen SM, Vaeth M, Pedersen DE, et al. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment. Now! Int J Radiat Oncol Biol Phys. 1995;32:1531–1534
  68. Dileto CL, Travis EL. Fibroblast radiosensitivity in vitro and lung fibrosis: Comparison between a fibrosing and non-fibrosing mouse strain. Radiat Res. 1996;146:61–67
  69. Ho AY, Atencio DP, Peters S, et al. Genetic predictors of adverse radiotherapy effects: The Gene-PARE project. Int J Radiat Oncol Biol Phys. 2006;65:646–655
  70. West CM, McKay MJ, Holscher T, et al. Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting. Int J Radiat Oncol Biol Phys. 2005;62:1264–1273
  71. Baumann M, Holscher T, Begg AC. Towards genetic prediction of radiation responses: ESTRO’s GENEPI project. Radiother Oncol. 2003;69:121–125
  72. Anscher MS, Crocker IR, Jirtle RL. Transforming growth factor-β1 expression in irradiated liver. Radiat Res. 1990;122:77–85
  73. Anscher MS, Peters WP, Reisenbichler H, et al. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med. 1993;328:1592–1598
  74. Li C, Wilson PB, Levine E, et al. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer. 1999;84:155–159
  75. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93–97
  76. El-Gamel A, Awad MR, Hasleton PS, et al. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. J Heart Lung Transplant. 1999;18:517–523
  77. Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014–1020
  78. El-Gamel A, Awad M, Sim E, et al. Transforming growth factor-beta1 and lung allograft fibrosis. Eur J Cardiothorac Surg. 1998;13:424–430
  79. Quarmby S, Fakhoury H, Levine E, et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol. 2003;79:137–143
  80. Anscher MS, Thrasher B, Rabbani Z, et al. Antitransforming growth factor-beta antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation. Int J Radiat Oncol Biol Phys. 2006;65:876–881
  81. Bonniaud P, Margetts PJ, Ask K, et al. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol. 2005;175:5390–5395
  82. Vallance BA, Gunawan MI, Hewlett B, et al. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol Gastrointest Liver Physiol. 2005;289:G116–G128
  83. Sime PJ, Xing Z, Graham FL, et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest. 1997;100:768–776

PII: S1053-4296(06)00112-3

doi: 10.1016/j.semradonc.2006.11.011

Seminars in Radiation Oncology
Volume 17, Issue 2 , Pages 149-155 , April 2007

Article Tools